Leerink Partners has hired Chris McCarthy as a Senior Managing Director, strengthening its Institutional Equities platform and expanding its healthcare sales capabilities.
McCarthy will be based in New York and report to Rob Leerink, Head of Institutional Equities.
He brings more than 25 years of experience working with institutional healthcare investors.
McCarthy joins from RBC Capital Markets, where he was ranked the No. 1 Healthcare Salesperson by Institutional Investor three times during the past five years.
Before RBC, he held healthcare sales roles at Bank of America and Cowen, now TD Cowen.
In his new role, McCarthy will work closely with Leerink’s research, sales, trading and capital markets teams.
The firm expects him to help deliver differentiated market intelligence and strategic advice to institutional investors while broadening Leerink’s relationships across the healthcare investment community.
Leerink Partners operates as a specialized healthcare investment bank providing advisory, capital raising, and institutional equities services.
Since inception, the firm has advised on approximately $85 billion of transactions and helped clients raise more than $225 billion.
KEY QUOTES:
“Chris is a highly respected healthcare sales professional who has earned an outstanding reputation across the industry through decades of building trusted relationships with investors. His market insight, client focus, and deep understanding of the healthcare landscape will help us expand our reach.”
Rob Leerink, Head Of Institutional Equities At Leerink Partners
“Leerink Partners has built the industry’s premier healthcare investment banking and institutional equities platform, with a longstanding reputation for delivering differentiated insights and exceptional client service.”
Chris McCarthy, Senior Managing Director At Leerink Partners
